Priority vs Standard Review: How FDA Prioritizes Generic Drug Applications
The FDA uses priority and standard review pathways to speed up access to generic drugs. Priority review cuts approval time to 8 months for first generics, shortage drugs, and complex products. A new pilot program rewards U.S. manufacturing to strengthen supply chains.
ReadMore